
Patients who undergo low anterior resection surgery for rectal cancer often face long-term challenges, including the development of Low Anterior Resection Syndrome (LARS), impacting bowel control and quality of life. In a study involving 115 patients, 70% experienced major LARS at a median follow-up of 4 years post-stoma reversal. Prolonged time to stoma reversal and adjuvant chemotherapy were linked to a higher risk of major LARS. Anorectal physiology testing, while associated with poorer outcomes, revealed certain measurable parameters that could identify patients at risk. The findings underscore the need to improve treatment options for sustained postoperative symptoms in rectal cancer survivors.
Like
Save
Share